Brief: Zevra Therapeutics’ CEO Issues Letter To Stockholders Highlighting Outlook For 2024
29/04/2024 12:41
April 29 (Reuters) - Zevra Therapeutics Inc ZVRA.O :
* ZEVRA THERAPEUTICS’ PRESIDENT AND CHIEF EXECUTIVE OFFICER
ISSUES
LETTER TO STOCKHOLDERS HIGHLIGHTING RECENT KEY ACCOMPLISHMENTS
AND OUTLOOK FOR 2024
Source text for Eikon: ID:nGNX609Cvh
Further company coverage: ZVRA.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Zevra Therapeutics
See all newsZevra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Zevra Therapeutics Q2 revenue rises 53% on MIPLYFFA sales
Zevra Therapeutics Inc expected to post earnings of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor